14% Increased chance of receiving a transplant1
Live Healthier, Better, Longer
More frequent treatments with home hemodialysis have been shown to lower risk of death.
Up to 75 percent of people with chronic kidney disease suffer from a heart complication called left ventricular hypertrophy (LVH).5,6
More frequent treatments can improve vitality and give you more energy to do the things you love.
Studies suggest that hormone level improvements may help to improve sexual function and patients report better satisfaction with physical intimacy.
Take Your Life Back
Robby"When I used to look in the mirror there was a guy looking back at me that just he wasn’t there. He was ready to check out. I don’t see that guy any more. For the first time in years I felt good. I started tour guiding again. I’ve started my own tour company now. NxStage gave me my life back."
Tina"It [dialysis] doesn’t interfere in any of our activities. My son recently joined the Navy and last Mother’s Day he graduated from boot camp and I got to go which is something I would not have gotten to do if I didn’t have NxStage"
Don"When I was on in-center after each treatment I was tired I would go home and sleep for hours. My motorcycle just sat in my parent’s garage. I didn’t see my grandkids. When I started more frequent home hemodialysis with System One I started to feel myself coming back from this dark place. My family recognizes me as being back. They see the life in me again."
Leo"In-center you have no control over your life. They schedule you, hook you up for 4 hours and at the end of the day I would walk out and I didn’t feel well. I even considered taking myself off dialysis because the lifestyle I wanted to live I wasn’t living. When my doctor described home hemodialysis I jumped on it right away."
Experience The Difference
Join the 8,000 patients who have experienced the difference of home hemodialysis with the System One. The NxStage System One is the most prescribed home hemodialysis machine in the United States.
Experience the Difference program is a one-week test-drive for more frequent home hemodialysis with the System One.*
Download Our Free Informational Booklet!
Despite the health benefits that more frequent home hemodialysis may provide to those with chronic kidney disease, this form of therapy is not for everyone. Home hemodialysis with the NxStage System One requires a patient and partner who are committed to being trained on and following the guidelines for proper system operation.
The reported benefits of home hemodialysis may not be experienced by all patients.
The NxStage System One is a prescription device and, like all medical devices, involves some risks. The risks associated with hemodialysis treatments in any environment include, but are not limited to, high blood pressure, fluid overload, low blood pressure, heart-related issues, and vascular access complications. The medical devices used in hemodialysis therapies may add additional risks including air entering the bloodstream, and blood loss due to clotting or accidental disconnection of the blood tubing set. When vascular access is exposed to more frequent use, infection of the site, and other access related complications may also be potential risks. Patients should consult with their doctor to understand the risks and responsibilities of home and/or more frequent hemodialysis using the NxStage System One.
Certain risks are unique to the home. Treatments at home are done without the presence of medical personnel and on-site technical support. Patients and their partners must be trained on what to do and how to get medical or technical help if needed.
Certain risks associated with hemodialysis treatment are increased when performing nocturnal therapy due to the length of treatment time and because therapy is performed while the patient and care partner are sleeping. These risks include, but are not limited to, blood access disconnects and blood loss during sleep, blood clotting due to slower blood flow or increased treatment time or both, and delayed response to alarms when waking from sleep. Patients should consult with their physician to understand the risks and responsibilities associated with home nocturnal hemodialysis using the NxStage System One.
These patients have given NxStage permission to share the experiences they have enjoyed with more frequent home therapy using the NxStage System One. Please note that another patient will not necessarily experience the same results reported by these patients. Also, training and treatment requirements reported by these patients are determined by their clinics. Your experiences and clinic requirements may differ.
- Weinhandl E, Liu J, Gilbertson D, Arneson T, Collins A. Transplant incidence in frequent hemodialysis and matched thrice-weekly hemodialysis patients. Poster presented at National Kidney Foundation Spring Clinical Meeting, 2012.
- Weinhandl ED, Lie J, Gilbertson DT, Arneson TJ, Collins AJ. Survival in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. J Am Soc Nephrol. 2012;23(5):895-904.
- FHN Trial Group. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010;363(24):2287-2300.
- Culleton BF, Walsh M, Klarenbach SW, et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life. JAMA. 2007; 298(11):1291-1299.
- London GM, Pannier B, Guerin AP, et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol. 2001;12(12):2759-2767.
- Cheung AK, Sarnak MJ, Yan GF, Berkoben M, Heyka R, Kaufman A, et al. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int. 2004;65(6):2380-2389.
- Jaber BL, Lee Y, Collins AJ, et al. Effect of daily hemodialysis on depressive symptoms and postdialysis recovery time: interim report from the FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study. Am J Kidney Dis. 2010;56(3):531-539.
- Kraus MA, Cox CG, Summitt CL, et al. Work and travel in a large Short Daily Hemodialysis (SDHD) program. Abstract presented at American Society of Nephrology Annual Conference, 2007.
- Pinciaroli AR. Results of daily hemodialysis in Catanzaro: 12-year experience with 22 patients treated for more than one year. Hemodial Int. 1998;2(1):12-17.
- Tennankore K, Nadeau-Fredette AC, Chan CT. Intensified home hemodialysis: clinical benefits, risks and target population. Nephrol Dial Transplant. 2014;29(7):1342-1349.
- Finkelstein FO, Schiller B, Daoui R, et al. At-home short daily hemodialysis improves the long-term health-related quality of life. Kidney Int. 2012;82(5): 561-569.
- Heidenheim PA, Muirhead N, Moist L, Lindsay RM. Patient quality of life on quotidian hemodialysis. Am J Kidney Dis. 2003;42(1)(suppl 1):S36-S41.
- Ting GO, Kjellstrand C, Freitas T, Carrie BJ, Zarghamee S. Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis. Am J Kidney Dis. 2003;42(5):1020-1035.
- Goldfarb-Rumyantzev AS, Leypoldt JK, Nelson N, Kutner NG, Cheung AK. A crossover study of short daily hemodialysis. Nephrol Dial Transplant. 2006;21:166-175.